UPDATE: JP Morgan Maintains Overweight On Humana, Raises Target To $448 As Firm Notes 'Flowing the HIF Repeal Through Estimates; Raising 2021, Initiating 2022 EPS'

Benzinga · 01/03/2020 18:01